Home
>
National Drug Code (NDC)
>
Glycopyrrolate
Glycopyrrolate - 55154-5739-8 - (Glycopyrrolate)
Drug Information of Glycopyrrolate
| Product NDC: | 55154-5739 |
| Proprietary Name: | Glycopyrrolate |
| Non Proprietary Name: | Glycopyrrolate |
| Active Ingredient(s): | .4 mg/2mL & nbsp; Glycopyrrolate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Glycopyrrolate
| Product NDC: | 55154-5739 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089335 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111025 |
Package Information of Glycopyrrolate
| Package NDC: | 55154-5739-8 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 BAG (55154-5739-8) > 2 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Glycopyrrolate
| NDC Code | 55154-5739-8 |
| Proprietary Name | Glycopyrrolate |
| Package Description | 1 VIAL, MULTI-DOSE in 1 BAG (55154-5739-8) > 2 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 55154-5739 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glycopyrrolate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20111025 |
| Marketing Category Name | ANDA |
| Labeler Name | Cardinal Health |
| Substance Name | GLYCOPYRROLATE |
| Strength Number | .4 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
